(Q41962727)

14 October 2017

Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine (English)

1 reference

14 October 2017

1 reference

pulmonary tuberculosis

1 reference

1 reference

1 reference

Hennie Geldenhuys

3

0 references

Lubbe Wiesner

Lubbe Wiesner

8

0 references

Paolo Denti

Paolo Denti

2

0 references

Helen McIlleron

Helen M McIlleron

12

0 references

Willem Albert Hanekom

7

Willem Hanekom

1 reference

14 October 2017

6

Mark Hatherill

1 reference

14 October 2017

1

Simbarashe P Zvada

1 reference

14 October 2017

9

Ulrika S H Simonsson

1 reference

14 October 2017

10

Amina Jindani

1 reference

14 October 2017

4

Sandra Meredith

1 reference

14 October 2017

Danelle van As

5

1 reference

14 October 2017

Thomas Harrison

11

1 reference

14 October 2017

language of work or name

English

0 references

publication date

14 May 2012

1 reference

Antimicrobial Agents and Chemotherapy

14 October 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

14 October 2017

56

1 reference

14 October 2017

8

1 reference

14 October 2017

4471-4473

1 reference

Mechanistic basis of using body size and maturation to predict clearance in humans

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Mechanism-based concepts of size and maturity in pharmacokinetics

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Selective role of sulfotransferase 2A1 (SULT2A1) in the N-sulfoconjugation of quinolone drugs in humans.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421597

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22585223

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22585223

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00404-12

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

22585223

1 reference